Metabolic syndrome: An emerging threat to renal function

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 5, 2007, Pages 869-871

  Ritz, Eberhard ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Nierenzentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; HUMAN; KIDNEY; KIDNEY DISEASE; METABOLIC SYNDROME X; NOTE; PATHOPHYSIOLOGY;

CHRONIC DISEASE; HUMANS; KIDNEY; KIDNEY DISEASES; METABOLIC SYNDROME X;

EID: 34548846676     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02350607     Document Type: Editorial

References (25)

1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS: A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352: 1138-1145, 2005
2. Hitzenberger K: R-QM: A contribution to the (deranged) metabolism (in patients with) vascular hypertension [in German]. Wiener Arch Innere Med 2: 189, 1921
3. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
5. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304, 2005
6. Reaven GM: The metabolic syndrome: Requiescat in pace. Clin Chem 51: 931-938, 2005
7. Bakker SJ, Gansevoort RT, de Zeeuw D: Metabolic syndrome: A fata morgana? Nephrol Dial Transplant 22: 15-20, 2007
8. Pambianco G, Costacou T, Orchard TJ: The prediction of major outcomes of type 1 diabetes: A 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate - The Pittsburgh Epidemiology of Diabetes Complications Study Experience. Diabetes Care 30: 1248-1254, 2007
9. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741, 2003
10. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140: 167-174, 2004
11. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003
12. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005
13. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Waden J, Ronnback M, Rosengard-Barlund M, Bjorkesten CG, Taskinen MR, Groop PH: Metabolic syndrome in type 1 diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28: 2019-2024, 2005
14. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37: 720-727, 2001
15. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
16. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L: Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 12: 195-200, 2003
17. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T: Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors. J Am Soc Nephrol 17: 3438-3446, 2006
18. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
19. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M: Metabolic syndrome and CKD in a general Japanese population: The Hisayama Study. Am J Kidney Dis 48: 383-391, 2006
20. Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, Batuman V, Lee CH, Whelton PK, He J: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 22: 1100-1106, 2007
21. Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V, Sritara P: The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 71: 693-700, 2007
22. Rashidi A, Ghanbarian A, Azizi F: Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2: 976-983, 2007
23. Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73: 1059-1064, 2006
24. Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MCE, Strippoli GFM, Belfiglio M, Tognoni G, Valentini M, Nicolucci A; on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group: Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study. Clin J Am Soc Nephrol 2: 984-991, 2007
25. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K: Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2: 883-888, 2007